Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis

被引：0
|
作者：
Shedko E.D. [1 ]
Tyumentseva M.A. [1 ]
机构：
[1] Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Moscow
来源：
Neuroscience and Behavioral Physiology | 2020年 / 50卷 / 5期
关键词：
autoimmune diseases; biomarkers; cerebrospinal fluid; multiple sclerosis;
D O I：
10.1007/s11055-020-00932-z
中图分类号：
学科分类号：
摘要：
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the spinal cord and brain. Detection of the disease at its initial stages is a difficult task as the causes and mechanisms of the manifestations of the disease remain unclear. Diagnosis of MS is a complex process. Studies of the molecular mechanisms of the disease and the search for biomarkers are among the key directions in the diagnosis of the disease. This review addresses potential biomarkers for multiple sclerosis detected in the cerebrospinal fluid. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：527 / 533
页数：6
相关论文
共 50 条
  • [11] Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis
    Dujmovic, Irena
    MULTIPLE SCLEROSIS INTERNATIONAL, 2011, 2011
  • [12] Cerebrospinal Fluid Biomarkers of Multiple Sclerosis Patients in Relapse and Remission
    Orbach, Rotem
    Gurevich, Michael
    Achiron, Anat
    NEUROLOGY, 2011, 76 (09) : A375 - A375
  • [13] Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis In Search of Biomarkers
    Alvermann, Sascha
    Hennig, Christian
    Stueve, Olaf
    Wiendl, Heinz
    Stangel, Martin
    JAMA NEUROLOGY, 2014, 71 (07) : 905 - 912
  • [14] Extracellular vesicles in cerebrospinal fluid as possible biomarkers for multiple sclerosis
    Salemi, G.
    Ragonese, P.
    Geraci, F.
    Allotta, E.
    Barreca, M. M.
    Realmuto, S.
    Mazzola, M. A.
    Sconzo, G.
    Savettieri, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 407 - 407
  • [15] Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
    Martynova, Ekaterina
    Goyal, Mehendi
    Johri, Shikhar
    Kumar, Vinay
    Khaibullin, Timur
    Rizvanov, Albert A.
    Verma, Subhash
    Khaiboullina, Svetlana F.
    Baranwal, Manoj
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [16] Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
    Virgilio, Eleonora
    Vecchio, Domizia
    Crespi, Ilaria
    Puricelli, Chiara
    Barbero, Paolo
    Galli, Giulia
    Cantello, Roberto
    Dianzani, Umberto
    Comi, Cristoforo
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3249 - 3257
  • [17] Cerebrospinal fluid biomarkers in patients with multiple sclerosis and significant cognitive impairment
    Ionete, C
    Padula, M
    Healey, K
    Scheithauer, BW
    Markopoulou, K
    ANNALS OF NEUROLOGY, 2004, 56 : S32 - S32
  • [18] Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
    Lorenzo Gaetani
    Nicola Salvadori
    Elena Chipi
    Lucia Gentili
    Angela Borrelli
    Lucilla Parnetti
    Massimiliano Di Filippo
    Neural Regeneration Research, 2021, 16 (01) : 36 - 42
  • [19] Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
    Villar, L. M.
    Picon, C.
    Costa-Frossard, L.
    Alenda, R.
    Garcia-Caldentey, J.
    Espino, M.
    Muriel, A.
    Alvarez-Cermeno, J. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (08) : 1169 - 1175
  • [20] Cerebrospinal Fluid Biomarkers Of Toxic Astrogliosis Correlate With Multiple Sclerosis Severity
    Masvekar, R. R.
    Bielekova, B.
    Barbour, C.
    Kosa, P.
    Milstein, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 130 - 130
12345